Extraterritoriality in patent law is not simply a question of whether a U.S. patent applies overseas. U.S. patent rights are generally limited to activities within the United States, yet events in other countries can still affect a patent’s validity, enforceability and the remedies available for infringement. For manufacturers, system integrators and technology companies operating across borders, the distinction matters when evaluating inventions, product sales and patent exposure.
Courts approach the issue against a general presumption that U.S. laws do not regulate conduct outside the country unless Congress clearly indicates otherwise. Patent law presents a complication: courts have often considered foreign activity when deciding whether a U.S. patent can be enforced, while treating foreign conduct differently when deciding whether someone has infringed that patent.
Why U.S. patent rights are not strictly territorial
A patent is granted under the law of a particular country. A U.S. patent does not, by itself, provide patent protection in other countries; companies seeking protection elsewhere generally need rights granted under those jurisdictions’ laws. At the same time, the U.S. patent system has long taken account of certain foreign events.
That produces an important distinction between foreign activity that affects the status or enforcement of a U.S. patent and foreign activity that is alleged to violate it. The first category can include publications used as prior art or a foreign sale that exhausts patent rights. The second concerns conduct that may give rise to infringement liability or remedies under U.S. law.
Foreign prior art can affect U.S. patent validity
Prior art is information or activity considered when assessing whether an invention meets requirements such as novelty and non-obviousness. Foreign patents and printed publications have long been available for consideration in evaluating U.S. patent claims. In other words, a disclosure does not need to originate in the United States to be relevant to whether a U.S. patent should have been granted.
The rules for activities involving a physical invention have also changed. Earlier versions of U.S. patent law generally limited certain public uses and sales to activity in the United States. The America Invents Act removed those geographic limits for relevant prior-art provisions. As a result, qualifying public uses and sales may take place anywhere in the world.
The Supreme Court’s decision in Helsinn Healthcare v. Teva Pharmaceuticals further clarified that a commercial sale can matter under the “on-sale” provision even when the buyer is required to keep the invention confidential. This means some nonpublic commercial activity may be relevant to patentability. For technical organizations, records of product development, licensing and sales activity across markets may therefore matter in assessing patent validity.
International patent exhaustion and the first sale
Patent exhaustion, also known as the first-sale doctrine, limits a patent owner’s ability to control a particular item after an authorized sale. The purchaser can generally use or resell that item, but exhaustion does not grant the right to make a new copy of the patented invention.
The geographic reach of exhaustion has been contested. Under domestic exhaustion, a sale outside the United States does not exhaust U.S. patent rights. Under international exhaustion, an authorized sale anywhere in the world can do so. This difference can affect the legal status of products imported into the United States after an overseas sale.
For years, the Federal Circuit applied a domestic approach, including in Jazz Photo. The Supreme Court later considered exhaustion in other contexts, including copyright, before addressing patent exhaustion in Impression Products v. Lexmark. The broader debate illustrates why teams handling international distribution should not assume that a foreign sale has the same effect across every type of intellectual property or under every legal regime.
Infringement and remedies raise different questions
Considering foreign conduct when assessing validity or exhaustion is not the same as imposing liability for acts abroad. The Patent Act generally ties direct infringement to specified conduct within the United States. Congress has also enacted provisions addressing certain cross-border situations, such as supplying components from the United States for combination abroad.
When a patent claim involves foreign conduct, courts must consider the presumption against extraterritoriality. The Supreme Court’s framework asks first whether Congress clearly indicated that a statute applies outside the United States. If not, the court considers whether the statute’s focus, applied to the facts, is domestic. Foreign events in a case do not automatically make the application of U.S. law extraterritorial; the location of the conduct relevant to the statute’s focus is also important.
Remedies can raise their own territorial questions. In WesternGeco v. ION Geophysical, the Supreme Court considered damages under the Patent Act in a case involving foreign activity. The decision brought attention to how domestic infringement can relate to losses connected with conduct abroad. It does not mean that every overseas sale or business consequence is automatically recoverable; the relationship between the conduct, the statutory provisions and the claimed remedy matters.
What cross-border technology teams should take away
The practical lesson is to distinguish the legal role of foreign activity rather than treating it as either always irrelevant or always within U.S. patent law. When reviewing a product or process, teams may need to consider:
- Patentability: Foreign publications, public uses and sales may be relevant prior art.
- Product transfers: An authorized overseas sale may affect whether U.S. patent rights remain enforceable against a particular item.
- Conduct and location: The place where components are made, supplied, combined or used can matter to infringement analysis.
- Potential remedies: The connection between domestic conduct and claimed losses should be assessed separately from the question of infringement.
These questions are especially relevant to organizations that develop products in one country, manufacture components in another and sell integrated systems in the United States. A cross-border supply chain does not erase the territorial limits of U.S. patent rights, but neither does territoriality make foreign activity irrelevant.
Conclusion
Extraterritoriality in patent law involves several distinct questions: whether foreign activity affects a patent’s validity, whether a sale exhausts rights in a particular item, and whether conduct or losses abroad can support infringement liability or remedies in the United States. Courts have not treated these questions identically. For industrial technology businesses, careful review of where activities occur—and how each activity relates to the patent issue at hand—provides a more reliable foundation for managing cross-border patent risk.